| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Assessment of metabolic biomarkers associated with hepatic steatosis in Crohn’s disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Cristina Suárez Ferrer, Marta Abadía, María Gema Crespo Sanchez, Jose Luis Rueda García, Antonio Olveira, Miriam Romero, Marta Molero-Luis, Eduardo Martin-Arranz, Maria Sanchez-Azofra, Araceli García, Clara Amiama Roig, Joaquín Poza Cordón, Laura García-Ramírez and Maria Dolores Martin-Arranz |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Luis Álvarez Grant awarded by the Instituto de Investigación Sanitaria IdiPAZ (IdiPAZ) in 2024 |
|
|
| Corresponding Author |
Cristina Suárez Ferrer, MD, PhD, Department of Gastroenterology, Hospital La Paz Institute for Health Research (IdiPAZ), La Paz University Hospital, Paseo de la Castellana 261, Madrid 28046, Spain. cristinajsuarezferrer@gmail.com |
| Key Words |
Crohn’s disease; Metabolic dysfunction-associated steatotic liver disease; Hepatic steatosis; Hepatokines; Angiopoietin-like protein 6; Fibroblast growth factor 21; Controlled attenuation parameter; Intestinal inflammation |
| Core Tip |
Active Crohn’s disease is associated with a higher prevalence of steatosis and increased angiopoietin-like protein 6 and fibroblast growth factor 21 levels, suggesting inflammation-related metabolic alterations. Controlled attenuation parameter may serve as a reliable non-invasive tool for steatosis detection in Crohn’s disease, although inflammatory activity should be considered in its interpretation. |
| Publish Date |
2026-10-20 03:52 |
| Citation |
Suárez Ferrer C, Abadía M, Crespo Sanchez MG, Rueda García JL, Olveira A, Romero M, Molero-Luis M, Martin-Arranz E, Sanchez-Azofra M, García A, Amiama Roig C, Poza Cordón J, García-Ramírez L, Martin-Arranz MD. Assessment of metabolic biomarkers associated with hepatic steatosis in Crohn’s disease. World J Gastroenterol 2026; 32(46): 121707
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i46/121707.htm |
| DOI |
https://doi.org/10.3748/wjg.121707 |
